Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors

Published:2022-12-30 Issue:2 Volume:43 Page:177-213
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Ghaedrahmati Farhoodeh¹^ORCID,Esmaeil Nafiseh¹²,Abbaspour Maryam³

Affiliation:

1. Department of Immunology School of Medicine Isfahan University of Medical Sciences Isfahan Iran

2. Research Institute for Primordial Prevention of Non‐Communicable Disease Isfahan University of Medical Sciences Isfahan Iran

3. Department of Pharmaceutical Biotechnology Faculty of Pharmacy Isfahan University of Medical Sciences Isfahan Iran

Funder

Isfahan University of Medical Sciences

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12394

Reference323 articles.

1. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

2. Harnessing the immune system to improve cancer therapy

3. Advancing to the era of cancer immunotherapy

4. A Nobel Prize‐worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens

5. Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC;Scientific Reports;2024-09-13

2. First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial;Med;2024-09

3. The basic biology of NK cells and its application in tumor immunotherapy;Frontiers in Immunology;2024-08-16

4. Strong capacity of differentiated PD-L1 CAR-modified UCB-CD34+ cells and PD-L1 CAR-modified UCB-CD34+-derived NK cells in killing target cells and restoration of the anti-tumor function of PD-1-high exhausted T Cells;Stem Cell Research & Therapy;2024-08-13

5. Therapeutic effect of small extracellular vesicles from cytokine-induced memory-like natural killer cells on solid tumors;Journal of Nanobiotechnology;2024-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3